Hypoglycaemia in diabetes

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 4, Issue 4, 2004, Pages 307-310

  MacLeod, Kenneth M ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Autonomic failure; Diabetes; Driving; Education; Employment; Hypoglycaemia; Type 1 diabetes; Type 2 diabetes

Indexed keywords

CHLORPROPAMIDE; GLIBENCLAMIDE; GLUCOSE; INSULIN; INSULIN GLARGINE; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN;

AUTONOMIC DYSFUNCTION; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; COMA; CONTINUOUS INFUSION; CONVULSION; DIABETES MELLITUS; DIET THERAPY; DRIVING ABILITY; EMPLOYMENT; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PREDICTION; REVIEW; RISK FACTOR; SYMPTOMATOLOGY; TECHNOLOGY;

EID: 4243105238     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.4-4-307     Document Type: Review

References (19)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-86.
2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352:837-53.
3. Amiel SA. Hypoglycaemia avoidance - technology and knowledge. Lancet 1998;352: 502-3.
4. Allen C, LeCaire T, Plata M, Daniels K et al; Wisconsin Diabetes Registry Project. Risk factors for frequent and severe hypoglycemia in type 1 diabetes. Diabetes Care 2001;24:1878-81.
5. Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Research Group. Diabetes 1997;46:271-8.
6. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Review. Diabetes Care 2003;26:1902-12.
7. Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med 2003;20: 1016-21.
8. Cryer PE. Hypoglycemia begets hypoglycemia in IDDM. Review. Diabetes 1993; 42:(12)1691-3.
9. Epidemiology of severe hypoglycaemia in the diabetes control and complications trial. The DCCT Research Group. Am J Med 1991;90:450-9.
10. Evers IM, ter Braak EW, de Valk HW, van Der School B et al. Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy. Diabetes Care 2002;25:554-9.
11. Gold AE, MacLeod KM, Frier B. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994;17:(7) 697-703.
12. Nordfeldt S, Samuelsson U. Serum ACE predicts severe hypoglycemia in children and adolescents with type 1 diabetes. Diabetes Care 2003;26:274-8.
13. Chico A, Vidal-Rios P, Subira M, Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 2003;26: 1153-7.
14. Boland E, Monsod T, Delucia M, Brandt CA et al. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001;24:(11)1858-62.
15. Owens DR, Zinman B, Bolli GB. Insulins today and beyond. Review. Lancet 2001;358: 739-46.
16. Barnett AH. A review of basal insulins. Review. Diabet Med 2003;20:873-85.
17. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Review. Diabetes Care 2002;25:593-98.
18. Cox DJ, Gonder-Frederick L, Polonsky W, Schlundt D et al. Blood glucose awareness training (BGAT-2): long-term benefits. Diabetes Care 2001;24:637-42.
19. MacLeod KM. Diabetes and driving: towards equitable, evidence-based decision making. Review. Diabet Med 1999;16: 282-90.